Related Experiment Video
Updated: Jul 21, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Revisiting resistant hypertension: a comprehensive review.
Ryan J Chan1, Wryan Helmeczi2, Swapnil S Hiremath1,3
1Division of Nephrology, Department of Medicine, University of Ottawa and the Ottawa Hospital, Ottawa, Ontario, Canada.
Resistant hypertension (RHT) is high blood pressure despite medication. Careful diagnosis and management are crucial for better cardiovascular outcomes.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Resistant hypertension (RHT) affects 10-30% of hypertensive patients.
- RHT is defined as blood pressure above targets despite three medications, including a diuretic.
- Risk factors include diabetes, obesity, and lifestyle; RHT increases cardiovascular risk.
Purpose of the Study:
- To review RHT definitions, diagnosis, and management.
- To discuss newer agents and research needs for RHT.
Main Methods:
- Literature review of RHT definitions and management strategies.
- Discussion of diagnostic challenges, including pseudoresistance and secondary hypertension.
- Exploration of pharmacologic and non-pharmacologic treatment options.
Main Results:
- Accurate diagnosis of RHT is essential, excluding pseudoresistance and secondary causes.
- Optimizing non-pharmacologic management and adherence is critical.
- Fourth-line agents and device therapies are considered after initial management.
Conclusions:
- Careful diagnosis and management of RHT are vital for reducing cardiovascular risk.
- Further research is needed on newer agents and advanced interventions for RHT.
- Optimizing treatment strategies can improve outcomes for patients with resistant hypertension.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

